France: ‘New Deal’ To Boost Access To Innovation, Curb Spending & Spur Investment

 
• By Ian Schofield

The French pharmaceutical industry association Leem has welcomed proposals on pricing, funding and access that are expected to feed into negotiations on the social security financing bill for 2024.

PillsEuros
Drug pricing is among the issues addressed in a new report for the French government • Source: Shutterstock

More from Europe

More from Geography